These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9270807)

  • 1. Improved absorption and bioavailability of cyclosporine A from a microemulsion formulation in lung transplant recipients affected with cystic fibrosis.
    Reynaud-Gaubert M; Viard L; Girault D; Bertault-Perez P; Guignard M; Metras D; Fuentes P
    Transplant Proc; 1997 Aug; 29(5):2450-3. PubMed ID: 9270807
    [No Abstract]   [Full Text] [Related]  

  • 2. Microemulsion formulation increases cyclosporin bioavailability in cystic fibrosis.
    Mikhail GW; Eadon H; Rogers P; Leaver N; Banner NR; Khaghani A; Yacoub MH
    Lancet; 1995 Dec; 346(8990):1638-9. PubMed ID: 7500788
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
    Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J
    Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile and variability of cyclosporine versus neoral in patients with cystic fibrosis after lung transplantation.
    Kesten S; Scavuzzo M; Chaparro C; Szalai JP
    Pharmacotherapy; 1998; 18(4):847-50. PubMed ID: 9692659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microemulsion formulation of cyclosporine in pediatric liver transplantation.
    Alberti D; Wallemacq P; Falchetti D; de Ville de Goyet J; Rigamonti W; Panzali A; Sokal E; Otte JB; Reding R
    Transplantation; 1996 Feb; 61(3):512-4. PubMed ID: 8610371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
    Loss GE; Brady L; Grewal HP; Siegel CT; Mead J; Bruce DS; Cronin DC; Woodle ES; Newell KA; Thistlethwaite JR; Millis JM
    Transplant Proc; 1998 Jun; 30(4):1435-6. PubMed ID: 9636581
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
    Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
    Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neoral and sandimmun cyclosporines for de novo lung transplantation in cystic fibrosis patients.
    Mikhail G; Eadon H; Leaver N; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1510-1. PubMed ID: 9636614
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P; Niese D
    Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
    Noble S; Markham A
    Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
    Ritschel WA
    Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute allograft rejection following conversion to a new cyclosporine formulation in pediatric renal transplant patients.
    Crocker J; Renton K; Wade A; McLellan H; Acott P
    Transplant Proc; 1998 Aug; 30(5):2002-5. PubMed ID: 9723369
    [No Abstract]   [Full Text] [Related]  

  • 13. An investigation of the pharmacokinetics, toxicity, and clinical efficacy of Neoral cyclosporin in cystic fibrosis patients.
    Mikhail G; Eadon H; Leaver N; Rogers P; Stephens D; Banner N; Khaghani A; Yacoub M
    Transplant Proc; 1997; 29(1-2):599-601. PubMed ID: 9123148
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients.
    Saint-Marcoux F; Marquet P; Jacqz-Aigrain E; Bernard N; Thiry P; Le Meur Y; Rousseau A
    Clin Pharmacokinet; 2006; 45(9):905-22. PubMed ID: 16928152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.
    Eisen HJ; Hobbs RE; Davis SF; Laufer G; Mancini DM; Renlund DG; Valantine H; Ventura H; Vachiery JL; Bourge RC; Canver CC; Carrier M; Costanzo MR; Copeland J; Dureau G; Frazier OH; Dorent R; Hauptman PJ; Kells C; Master R; Michaud JL; Paradis I; Smith A; Vanhaecke J; Mueller EA
    Transplantation; 1999 Sep; 68(5):663-71. PubMed ID: 10507486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved cyclosporine bioavailability in black pediatric liver transplant recipients after administration of the microemulsion formulation.
    Cooney GF; Dunn SP; Sommerauer J; Lindsay C; McDiarmid S; Choc MG; Smith HT; Chang CT; Wong RL
    Liver Transpl Surg; 1999 Mar; 5(2):112-8. PubMed ID: 10071350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoral conversion study: shift from Sandimmune classic formulation to Sandimmune Neoral in heart and lung transplant patients.
    Svendsen U; Larsen K; Allermand H; Thayssen P; Jensen S; Pettersson G
    Transplant Proc; 1995 Dec; 27(6):3477. PubMed ID: 8540057
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of a new pulmonary cyclosporine a powder formulation for prevention of transplant rejection in rats.
    Zijlstra GS; Wolting J; Prop J; Petersen AH; Hinrichs WL; Uges DR; Kerstjens HA; van der Bij W; Frijlink HW
    J Heart Lung Transplant; 2009 May; 28(5):486-92. PubMed ID: 19416778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoral cyclosporine.
    Canafax DM
    Transplant Proc; 1996 Apr; 28(2):867. PubMed ID: 8623439
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of immunosuppression by microemulsion cyclosporine in liver transplantation.
    Rasmussen A; Hjortrup A; Hansen B; Heslet L; Kirkegaard P
    Transplantation; 1996 Oct; 62(7):1031-3. PubMed ID: 8878402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.